{"id":3565,"count":7,"description":"Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder affecting 5\u201310% of adults, characterised by abdominal pain associated with altered bowel habit. Inflammatory bowel disease (IBD \u2014 ulcerative colitis and Crohn's disease) is a distinct group of immune-mediated chronic inflammatory conditions affecting younger adults disproportionately. The MedsBase IBS Treatment catalogue groups medications for both. Merk:<\/strong> the category name historically said \"IBS\" but most products are IBD-specific (mesalamine, sulfasalazine) \u2014 we are reorganising. All products are supplied by WHO-GMP-sertifiserte produsenter<\/strong>.\n\n5-ASA \/ mesalamin \u2014 vedlikeholdsbehandling og milde til moderate oppbluss av ulcer\u00f8s kolitt.<\/strong> Oralt mesalamin (5-aminosalicylsyre) er f\u00f8rstevalg ved vedlikeholdsbehandling av ulcer\u00f8s kolitt og effektivt ved milde til moderate oppbluss. De ulike merkene varierer i frigj\u00f8ringsm\u00f8nster (kontrollert frigj\u00f8ring pH-avhengig, tidsavhengig, multi-matrix) som bestemmer hvor i tarmen det aktive stoffet frigj\u00f8res \u2014 tilpass merkevalg etter sykdomsutbredelse. Lagerf\u00f8rt som Mesacol<\/a>, Mesacol OD<\/a> (en gang daglig kontrollert frigj\u00f8ring for distal sykdom), og Asacol<\/a> (n\u00e5r p\u00e5 lager). Topisk mesalamin (suppositorier, skum) for distal proktitt er listet i v\u00e5r Gastro Helse-kategori som Pentasa Suppositorier.\n\nSulfasalazin \u2014 ved IBD og revmatoid artritt.<\/strong> Sulfasalazin kombinerer 5-ASA med sulfapyridin (en azo-binding-b\u00e6rer som frigj\u00f8r 5-ASA i tykktarmen). Standarddose ved ulcer\u00f8s kolitt er 2\u20134 g daglig i delte doser. Lagerf\u00f8rt som Sazo<\/a> og Salazar<\/a>. Mesalamin med renere bivirkningsprofil foretrekkes vanligvis ved IBD; sulfasalazin er fortsatt nyttig der IBD-assosiert artropati eller revmatoid artritt forekommer (sulfapyridin-delen har DMARD-aktivitet).\n\nMebeverin \u2014 antispasmodikum ved IBS.<\/strong> Mebeverin (et glattmuskel-antispasmodikum) er f\u00f8rstevalg ved IBS med dominerende kramper og spasmer \u2014 tas 20 minutter f\u00f8r m\u00e5ltider. Lagerf\u00f8rt som Colospa<\/a>. Bivirkningsprofilen er gunstig; beskjent evidensgrunnlag fra eldre studier.\n\nRifaximin \u2014 ved IBS-D og SIBO.<\/strong> Rifaximin er et ikke-absorbert luminalt antibiotikum med FDA-godkjenning for IBS-D og bredere bruk ved bakteriell overvekst i tynntarmen (SIBO) og hepatisk encefalopati. Behandlingsforl\u00f8pet er 550 mg tre ganger daglig i 2 uker; symptomforbedring vedvarer i m\u00e5neder hos mange respondere. Lagerf\u00f8rt som Rifagut<\/a>.\n\nWhat's NOT here.<\/strong> Biologic therapy (infliximab, adalimumab, vedolizumab, ustekinumab, tofacitinib) for moderate-severe IBD requires specialist initiation and monitoring \u2014 not stocked. Corticosteroids for IBD flares: oral budesonide for ileal Crohn's and right-sided UC is in our Gastro Health category as Budez CR; systemic prednisolone is in Pain Relief Medication.\n\nHvordan velge.<\/strong> Mild-moderate ulcerative colitis \u2192 oral mesalamine first-line + topical 5-ASA for distal disease + check adherence. Mild-moderate Crohn's \u2192 mesalamine has limited evidence (works in colonic disease only); budesonide for ileal disease. IBS-C (constipation-predominant) \u2192 osmotic \/ stimulant laxatives (see Constipation Medicine category) \u00b1 linaclotide \/ lubiprostone where available. IBS-D (diarrhoea-predominant) \u2192 rifaximin 2-week course; consider eluxadoline. IBS-M (mixed) \u2192 antispasmodic (mebeverine) + lifestyle \/ FODMAP diet trial. Refractory or alarm features (weight loss, blood, anaemia, age > 50, family history of IBD or CRC) \u2192 urgent gastroenterology referral.\n\nViktig.<\/strong> IBD flares require tighter management than IBS (significant disease can be silent on standard therapy, and untreated flares progress to complications including stricture, fistula, dysplasia, and need for colectomy). Annual review with calprotectin \/ endoscopy as appropriate. Pregnancy: most 5-ASAs and sulfasalazine are continued through pregnancy; folic acid supplementation needed for sulfasalazine. Methotrexate and many biologics carry pregnancy restrictions. New diarrhoea in IBD or worsening symptoms can be C. difficile \u2014 test before assuming flare.\n\nAll MedsBase IBS Treatment products ship from WHO-GMP-sertifiserte produsenter<\/strong> med diskret emballasje og er dekket av v\u00e5r Reshipment Assurance Policy<\/a>.\n\n2026 buyer's guide:<\/strong> Se v\u00e5r kortliste Beste IBS & IBD-behandlinger 2026<\/a> for rangert utvalg, sammenligningstabell, doseringsnotater og beslutningssnarvei.","link":"https:\/\/medsbase.com\/nb\/irritable-bowel-syndrome-ibs-treatment\/","name":"Behandling av irritabel tarm (IBS)","slug":"irritable-bowel-syndrome-ibs-treatment","taxonomy":"product_cat","parent":3223,"meta":[],"menu_order":0,"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat\/3565","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat"}],"about":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/taxonomies\/product_cat"}],"up":[{"embeddable":true,"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product_cat\/3223"}],"wp:post_type":[{"href":"https:\/\/medsbase.com\/nb\/wp-json\/wp\/v2\/product?product_cat=3565"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}